These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 7529974)
1. Lipocortin 1 and hypothalamo-pituitary function in the rat. Taylor AD; Loxley HD; Flower RJ; Buckingham JC Ann N Y Acad Sci; 1994 Nov; 746():441-5. PubMed ID: 7529974 [No Abstract] [Full Text] [Related]
2. Lipocortin 1 mediates an early inhibitory action of glucocorticoids on the secretion of ACTH by the rat anterior pituitary gland in vitro. Taylor AD; Cowell AM; Flower J; Buckingham JC Neuroendocrinology; 1993 Oct; 58(4):430-9. PubMed ID: 7506818 [TBL] [Abstract][Full Text] [Related]
3. Evidence from immunoneutralization and antisense studies that the inhibitory actions of glucocorticoids on growth hormone release in vitro require annexin 1 (lipocortin 1). Taylor AD; Christian HC; Morris JF; Flower RJ; Buckingham JC Br J Pharmacol; 2000 Dec; 131(7):1309-16. PubMed ID: 11090102 [TBL] [Abstract][Full Text] [Related]
4. Effects of lipocortin 1 and dexamethasone on the secretion of corticotrophin-releasing factors in the rat: in vitro and in vivo studies. Loxley HD; Cowell AM; Flower RJ; Buckingham JC J Neuroendocrinol; 1993 Feb; 5(1):51-61. PubMed ID: 8485543 [TBL] [Abstract][Full Text] [Related]
5. Dexamethasone inhibits the release of TSH from the rat anterior pituitary gland in vitro by mechanisms dependent on de novo protein synthesis and lipocortin 1. Taylor AD; Flower RJ; Buckingham JC J Endocrinol; 1995 Dec; 147(3):533-44. PubMed ID: 8543924 [TBL] [Abstract][Full Text] [Related]
6. Priming of the anterior pituitary with corticotropin-releasing hormone in vitro does not facilitate an ACTH response to interleukin-1 beta. Jessop DS; Lightman SL Immunol Lett; 1994 Jul; 41(2-3):225-8. PubMed ID: 8002042 [TBL] [Abstract][Full Text] [Related]
7. The role of lipocortin 1 (LC1) in the steroid feedback control of hypothalamo-pituitary-adrenocortical function. In vivo studies. Taylor AD; Loxley HD; Flower RJ; Buckingham JC Ann N Y Acad Sci; 1994 Nov; 746():446-8. PubMed ID: 7825911 [No Abstract] [Full Text] [Related]
8. Changes in adrenocorticotropic hormone (ACTH) release from the cultured anterior pituitary cells of streptozotocin-induced diabetic rats. Gohshi A; Honda K; Tominaga K; Takano Y; Motoya T; Yamada K; Kamiya H Biol Pharm Bull; 1998 Aug; 21(8):795-9. PubMed ID: 9743244 [TBL] [Abstract][Full Text] [Related]
9. Vasopressin potentiates cyclic AMP accumulation and ACTH release induced by corticotropin-releasing factor (CRF) in rat anterior pituitary cells in culture. Giguere V; Labrie F Endocrinology; 1982 Nov; 111(5):1752-4. PubMed ID: 6290198 [No Abstract] [Full Text] [Related]
10. Activation of protein kinase C and L calcium channels enhances binding of biotinylated corticotropin-releasing hormone by anterior pituitary corticotropes. Childs GV; Unabia G Mol Endocrinol; 1989 Jan; 3(1):117-26. PubMed ID: 2464751 [TBL] [Abstract][Full Text] [Related]
11. Regulation of ACTH secretion from corticotrophs: the interaction of vasopressin and CRF. Bilezikjian LM; Vale WW Ann N Y Acad Sci; 1987; 512():85-96. PubMed ID: 2831787 [No Abstract] [Full Text] [Related]
12. Role of lipoxygenase metabolites of arachidonic acid in the regulation of adrenocorticotropin secretion by perifused rat anterior pituitary cells. Won JG; Orth DN Endocrinology; 1994 Oct; 135(4):1496-503. PubMed ID: 7523100 [TBL] [Abstract][Full Text] [Related]
13. Hypothalamo-pituitary-interrenal responses to opioid substances in the trout. I. Effects of morphine on the release in vitro of corticotrophin-releasing activity from the hypothalamus and corticotrophin from the pituitary gland. Bird DJ; Buckingham JC; Baker BI; Mukherjee S Gen Comp Endocrinol; 1987 Oct; 68(1):33-9. PubMed ID: 2822526 [TBL] [Abstract][Full Text] [Related]
14. Influence of various steroids on the production in vitro of corticotrophin releasing hormone and corticotrophin [proceedings]. Buckingham JC J Endocrinol; 1979 Oct; 83(1):38P-39P. PubMed ID: 230275 [No Abstract] [Full Text] [Related]
15. Corticotrope response to removal of releasing factors and corticosteroids in vivo. Dallman MF; Makara GB; Roberts JL; Levin N; Blum M Endocrinology; 1985 Nov; 117(5):2190-7. PubMed ID: 2995008 [TBL] [Abstract][Full Text] [Related]
16. Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis. Chowdrey HS; Larsen PJ; Harbuz MS; Jessop DS; Aguilera G; Eckland DJ; Lightman SL Br J Pharmacol; 1995 Nov; 116(5):2417-24. PubMed ID: 8581278 [TBL] [Abstract][Full Text] [Related]
17. Annexin 1 (lipocortin 1) mediates the glucocorticoid inhibition of cyclic adenosine 3',5'-monophosphate-stimulated prolactin secretion. Taylor AD; Philip JG; John CD; Cover PO; Morris JF; Flower RJ; Buckingham JC Endocrinology; 2000 Jun; 141(6):2209-19. PubMed ID: 10830310 [TBL] [Abstract][Full Text] [Related]
18. Functional activity of the hypothalamo-pituitary complex in the rat after betamethasone treatment. Buckingham JC; Hodges JR J Endocrinol; 1977 Aug; 74(2):297-302. PubMed ID: 197190 [TBL] [Abstract][Full Text] [Related]
19. Synthetic corticoliberin needs arginine vasopressin for full corticotropin releasing activity. Bény JL; Baertschi AJ Experientia; 1982 Sep; 38(9):1078-9. PubMed ID: 6290259 [No Abstract] [Full Text] [Related]
20. Arginine vasopressin and corticotropin releasing factor: binding to ovine anterior pituitary membranes. Shen PJ; Clarke IJ; Canny BJ; Funder JW; Smith AI Endocrinology; 1990 Nov; 127(5):2085-9. PubMed ID: 2226302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]